Sussex Pathology Network to Deploy Clinisys Laboratory Information System

ClinisysThe Sussex Pathology Network has chosen Clinisys for a laboratory information system (LIMS) that will help its labs to collaborate, building on the supportive relationship that developed during the COVID-19 pandemic.

A single, hosted instance of WinPath Enterprise will replace the existing four live LIMS systems in use at the three trusts and seven laboratories within the network, of which two are at the end of their life.

The replacement of these LIMS systems is crucial to ensure that the labs maintain their capability to deliver a comprehensive range of pathology services, supporting vital aspects such as diagnosis and treatment decisions, blood transfusion, and trauma care.

An implementation team will work alongside laboratory and IT staff to make sure the new LIMS also supports consistent, efficient, and high-quality processes - so clinicians and patients receive the same service, wherever they work or live.

Emily Gaskell, programme director, pathology, at NHS Sussex, said: "During the Covid-19 pandemic, our pathology laboratories worked more closely together, and that encouraged us to move forward and adopt the NHS England model for pathology networks.

"However, because most of the labs are spread along a long, thin, coastal patch, with very poor road communications, a hub and spoke model for all work is impractical.

"Instead, we want to focus on creating a consistent pathology service, so it doesn't matter whether you get a test in Rye or in Chichester; you will get the same test, and the same quality of results, in the same appropriate timeframe.

"To do that, one LIMS is essential. We see Clinisys WinPath as a key enabler for the network, and critical to improving services for people in Sussex."

The Sussex Pathology Network serves three trusts: East Sussex Healthcare NHS Trust, University Hospitals Sussex NHS Foundation Trust, and Queen Victoria Hospital NHS Foundation Trust.

The two acute trusts; East Sussex Healthcare NHS Trust and University Hospitals Sussex NHS Foundation Trust serve a population of around 2.3 million people, while Queen Victoria Hospital provides specialist burns and plastic surgery to a much larger population covering Sussex, Kent, Surrey and parts of South London.

Across the three trusts more than 7 million tests are carried out each year, and demand is growing by 5% per year. WinPath Enterprise will provide a stable, safe and secure platform for these essential services.

It will also enable better communications so laboratories can share workload and expertise, and support remote working. And, in time, it will enable the introduction of automation and AI technologies, so highly trained pathologists can focus on urgent and complex cases, where their expertise is most needed.

Emily Gaskell said: "This is not the only project that the network has on. We also need to deliver our business-as-usual service, invest in our operating model and workforce, and secure new equipment and communications.

"But we are very keen to progress. The new LIMS is an important first step towards our vision for all clinicians, patients and residents across Sussex to have access to a seamless pathology service, with the right test in the right place at the right time - every time."

Implementation is at an early stage, but the aim is to roll-out the new LIMS site by site, and to have the first two sites live by December next year.

Felice Di Rienzo, professional services director at Clinisys said: "We are delighted to be working with the Sussex Pathology Service on the deployment of this new LIMS. The project team want to work at pace, and we are absolutely up for that.

"We look forward to standing alongside the implementation team and the network's clinicians as they roll-out Clinisys WinPath as a stable, secure and safe platform for pathology services today and in the future."

About Clinisys

Clinisys enables healthier and safer communities as a global provider of intelligent diagnostic informatics solutions and expertise that redefine the modern laboratory across healthcare, life sciences, public health and safety. Millions of laboratory results and data insights are generated every day using Clinisys' platform and cloud-based solutions in over 3,000 laboratories across 34 countries.

Most Popular Now

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

To be Happier, Take a Vacation... from Y…

Today, nearly every American - 91% - owns a cellphone that can access the internet, according to the Pew Research Center. In 2011, only about one-third did. Another study finds...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI Revolutionizes Glaucoma Care

Imagine walking into a supermarket, train station, or shopping mall and having your eyes screened for glaucoma within seconds - no appointment needed. With the AI-based Glaucoma Screening (AI-GS) network...

North Cumbria Integrated Care Signs 10-Y…

North Cumbria Integrated Care NHS Foundation Trust (NCIC) has signed a long-term agreement for use of the Alcidion Miya Precision platform, to provide an electronic patient record (EPR) for the...

AI Accelerates Discovery of Neurodevelop…

Researchers have developed an artificial intelligence (AI) approach that accelerates the identification of genes that contribute to neurodevelopmental conditions such as autism spectrum disorder, epilepsy and developmental delay. This new...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...